New cryo-electron microscopy facility to tackle critical research issues
A Nobel prize-winning technique that underpins worldwide efforts to understand and treat diseases, and develop new drugs and medical therapies...
Can we really trust AI?
TRuST Scholarly Network hosts conversations on the transformational impact of artificial intelligence, big data and innovating responsibly.
NUS’ Arts For All framework to infuse the arts into student life
The arts support framework will enhance experiential and interdisciplinary learning through greater participation in the arts.
Teenage depression rates more than double in four decades – study
The prevalence of teenage depression in New Zealand has more than doubled since the 1980s, a new University of Otago-led study reveals.
Can blood be used to predict age-related diseases? U of T researchers bet it...
How much can a simple blood sample tell us about a person’s health? Can it give clues about whether a person will develop cardiovascular disease or leukemia? Can it predict how severe a person’s heart disease will be?
Contextual offer student receives prestigious Fulbright Scholarship
A University of Bristol graduate with a zeal to improve the world has been awarded a prestigious Fulbright Scholarship.
University of Bristol academic’s Radio 4 drama Man Friday wins prestigious award
University of Bristol lecturer Dr Edson Burton has been announced as the winner of the 2025 Tinniswood Award which recognises the best audio drama script of the year.
Academic conference on Sino-EU relations held at University of Macau
The Jean Monnet Chair (JMC) Academic Conference: ‘European Union-China Relations from the Perspective of Global Governance’...
Arthritis drugs save lives of hospitalised Covid-19 patients
Drugs used to treat arthritis, known as interleukin-6 antagonists, reduce deaths and the need for mechanical ventilation among people hospitalised with Covid-19...
Oxford coronavirus vaccine produces strong immune response in older adults
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
- Advertisement -
